These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31963134)

  • 41. Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II.
    Yokoi T; Yokoi K; Akiyama K; Higuchi T; Shimada Y; Kobayashi H; Sato T; Ohteki T; Otsu M; Nakauchi H; Ida H; Ohashi T
    Mol Genet Metab; 2016 Nov; 119(3):232-238. PubMed ID: 27590924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation.
    Langereis EJ; den Os MM; Breen C; Jones SA; Knaven OC; Mercer J; Miller WP; Kelly PM; Kennedy J; Ketterl TG; O'Meara A; Orchard PJ; Lund TC; van Rijn RR; Sakkers RJ; White KK; Wijburg FA
    J Bone Joint Surg Am; 2016 Mar; 98(5):386-95. PubMed ID: 26935461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II.
    Higuchi T; Shimizu H; Fukuda T; Kawagoe S; Matsumoto J; Shimada Y; Kobayashi H; Ida H; Ohashi T; Morimoto H; Hirato T; Nishino K; Eto Y
    Mol Genet Metab; 2012 Sep; 107(1-2):122-8. PubMed ID: 22704483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses.
    Frawley G; Fuenzalida D; Donath S; Yaplito-Lee J; Peters H
    Paediatr Anaesth; 2012 Aug; 22(8):737-44. PubMed ID: 22381044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].
    Giugliani R; Federhen A; Muñoz Rojas MV; Vieira TA; Artigalás O; Pinto LL; Azevedo AC; Acosta AX; Bomfim C; Lourenço CM; Kim CA; Horovitz D; Souza DB; Norato D; Marinho D; Palhares D; Santos ES; Ribeiro E; Valadares ER; Guarany F; De Lucca GR; Pimentel H; Souza IN; Corrêa Neto J; Fraga JC; Góes JE; Cabral JM; Simeonato J; Llerena JC; Jardim LB; Giuliani Lde R; Silva LC; Santos M; Moreira MA; Kerstenetzky M; Ribeiro M; Ruas N; Barrios P; Aranda P; Honjo R; Boy R; Costa R; Souza CF; Alcântara FF; Avilla SG; Fagondes S; Martins AM
    Rev Assoc Med Bras (1992); 2010; 56(3):271-7. PubMed ID: 20676532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Allogeneic hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis type 1: a case report].
    Ou RM; Wang L; Zheng LL; Yao MD; Jiang WT; Zhou CH
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):181-3. PubMed ID: 16787585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
    Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
    Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
    Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
    Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current and potential therapeutic strategies for mucopolysaccharidoses.
    Noh H; Lee JI
    J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses.
    Muenzer J
    Mol Genet Metab; 2014 Feb; 111(2):63-72. PubMed ID: 24388732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation.
    Bjoraker KJ; Delaney K; Peters C; Krivit W; Shapiro EG
    J Dev Behav Pediatr; 2006 Aug; 27(4):290-6. PubMed ID: 16906003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biomarkers in patients with mucopolysaccharidosis type II and IV.
    Fujitsuka H; Sawamoto K; Peracha H; Mason RW; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab Rep; 2019 Jun; 19():100455. PubMed ID: 30775257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aortic Root Dilatation in Mucopolysaccharidosis I-VII.
    Bolourchi M; Renella P; Wang RY
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
    Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
    Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucopolysaccharidoses: early diagnostic signs in infants and children.
    Galimberti C; Madeo A; Di Rocco M; Fiumara A
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):133. PubMed ID: 30442162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
    Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
    Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
    Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parents' experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS).
    Somanadhan S; Larkin PJ
    Orphanet J Rare Dis; 2016 Oct; 11(1):138. PubMed ID: 27724940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Open issues in Mucopolysaccharidosis type I-Hurler.
    Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M
    Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.
    Boucher AA; Miller W; Shanley R; Ziegler R; Lund T; Raymond G; Orchard PJ
    Orphanet J Rare Dis; 2015 Aug; 10():94. PubMed ID: 26245762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.